Last reviewed · How we verify
Transplantation of cord blood expanded with UM171
Transplantation of cord blood expanded with UM171 is a Biologic drug developed by Maisonneuve-Rosemont Hospital. It is currently in Phase 1 development.
At a glance
| Generic name | Transplantation of cord blood expanded with UM171 |
|---|---|
| Sponsor | Maisonneuve-Rosemont Hospital |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- US Study of ECT-001-CB in Pediatric and Young Adult Patients With High-Risk Myeloid Malignancies (PHASE1, PHASE2)
- US Study of UM171-Expanded CB in Patients With High Risk Leukemia/Myelodysplasia (PHASE2)
- ECT-001 (UM171) Expanded Cord Blood Transplant to Treat High-risk Multiple Myeloma (PHASE1, PHASE2)
- A Study Testing an Improved Dose of UM171 to Help Make Cord Blood Transplants More Effective and Safe. (PHASE1, PHASE2)
- UM171 Expanded Cord Blood In Patients With High-Risk Acute Leukemia/Myelodysplasia (PHASE2)
- US Phase I Study of ECT-001-CB in Patients With Sickle-Cell Disease (PHASE1)
- Expanded Cord Blood in Patients in Need of an Allogeneic Stem Cell Transplant (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Transplantation of cord blood expanded with UM171 CI brief — competitive landscape report
- Transplantation of cord blood expanded with UM171 updates RSS · CI watch RSS
- Maisonneuve-Rosemont Hospital portfolio CI
Frequently asked questions about Transplantation of cord blood expanded with UM171
What is Transplantation of cord blood expanded with UM171?
Transplantation of cord blood expanded with UM171 is a Biologic drug developed by Maisonneuve-Rosemont Hospital.
Who makes Transplantation of cord blood expanded with UM171?
Transplantation of cord blood expanded with UM171 is developed by Maisonneuve-Rosemont Hospital (see full Maisonneuve-Rosemont Hospital pipeline at /company/maisonneuve-rosemont-hospital).
What development phase is Transplantation of cord blood expanded with UM171 in?
Transplantation of cord blood expanded with UM171 is in Phase 1.